Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Products In Brief

This article was originally published in The Tan Sheet

Executive Summary

Symbollon takes supplement route: IoGen launches as a dietary supplement for women's breast health after Symbollon Pharmaceuticals' application with FDA seeking medical food approval stalled, said a spokeswoman for the Medfield, Mass., biotech firm. Symbollon completed eight clinical trials evaluating the effects of its molecular iodine compound on mastalgia and fibrosis in more than 2,000 patients. Starting in February, IoGen will be available in health food stores, online and through gynecologists, at a suggested retail price of $29.99 for 30 tablets

You may also be interested in...



Symbollon expands Iogen distribution

New England Vitamin Brokers will expand the presence of Symbollon Pharmaceuticals Inc.'s Iogen women's breast health supplement in New England. Medfield, Mass.-based Symbollon said June 16 it is exploring additional retail distribution channels for Iogen, which launched in February touting clinically proven effects in women with fibrocystic breast disease (1"The Tan Sheet" Feb. 22, 2010). NEVB Director Michael Goolkasian called Iogen "a truly unique product supported by extensive clinical data.

Symbollon expands Iogen distribution

New England Vitamin Brokers will expand the presence of Symbollon Pharmaceuticals Inc.'s Iogen women's breast health supplement in New England. Medfield, Mass.-based Symbollon said June 16 it is exploring additional retail distribution channels for Iogen, which launched in February touting clinically proven effects in women with fibrocystic breast disease (1"The Tan Sheet" Feb. 22, 2010). NEVB Director Michael Goolkasian called Iogen "a truly unique product supported by extensive clinical data.

Symbollon expands Iogen distribution

New England Vitamin Brokers will expand the presence of Symbollon Pharmaceuticals Inc.'s Iogen women's breast health supplement in New England. Medfield, Mass.-based Symbollon said June 16 it is exploring additional retail distribution channels for Iogen, which launched in February touting clinically proven effects in women with fibrocystic breast disease (1"The Tan Sheet" Feb. 22, 2010). NEVB Director Michael Goolkasian called Iogen "a truly unique product supported by extensive clinical data.

Topics

UsernamePublicRestriction

Register

PS103821

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel